| abstract |
The present invention relates to the use of antagonists of interleukin 1 receptor type 1 (IL-1R1) for the manufacture of a medicament for treating, preventing or inhibiting lung inflammation or respiratory disease. In some embodiments described herein, the medicament is for topical administration to lung tissue. Also disclosed are methods of treating lung inflammation or respiratory disease. |